217 related articles for article (PubMed ID: 31422126)
1. Imaging Cardiac Sarcoidosis With FLT-PET Compared With FDG/Perfusion-PET: A Prospective Pilot Study.
Martineau P; Pelletier-Galarneau M; Juneau D; Leung E; Nery PB; de Kemp R; Beanlands R; Birnie D
JACC Cardiovasc Imaging; 2019 Nov; 12(11 Pt 1):2280-2281. PubMed ID: 31422126
[No Abstract] [Full Text] [Related]
2. Prognostic Impact of Extent, Severity, and Heterogeneity of Abnormalities on
Sperry BW; Tamarappoo BK; Oldan JD; Javed O; Culver DA; Brunken R; Cerqueira MD; Hachamovitch R
JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):336-345. PubMed ID: 28823747
[TBL] [Abstract][Full Text] [Related]
3. Myocardial Blood Flow and Inflammatory Cardiac Sarcoidosis.
Kruse MJ; Kovell L; Kasper EK; Pomper MG; Moller DR; Solnes L; Chen ES; Schindler TH
JACC Cardiovasc Imaging; 2017 Feb; 10(2):157-167. PubMed ID: 28109920
[TBL] [Abstract][Full Text] [Related]
4. Cardiac sarcoidosis: the complementary role of 18F-FDG PET and MRI.
Van Schandevyl S; Waterschoot R; De Vos N; Devos D; Goethals I
J Cardiovasc Med (Hagerstown); 2020 Apr; 21(4):335-336. PubMed ID: 31809284
[No Abstract] [Full Text] [Related]
5. Hybrid Magnetic Resonance Imaging and Positron Emission Tomography With Fluorodeoxyglucose to Diagnose Active Cardiac Sarcoidosis.
Dweck MR; Abgral R; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Palmisano A; Miller MA; Lala A; Chang HL; Sanz J; Contreras J; Narula J; Fuster V; Padilla M; Fayad ZA; Kovacic JC
JACC Cardiovasc Imaging; 2018 Jan; 11(1):94-107. PubMed ID: 28624396
[TBL] [Abstract][Full Text] [Related]
6. Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.
Blankstein R; Osborne M; Naya M; Waller A; Kim CK; Murthy VL; Kazemian P; Kwong RY; Tokuda M; Skali H; Padera R; Hainer J; Stevenson WG; Dorbala S; Di Carli MF
J Am Coll Cardiol; 2014 Feb; 63(4):329-36. PubMed ID: 24140661
[TBL] [Abstract][Full Text] [Related]
7. Repeatability and Optimization of FDG Positron Emission Tomography for Evaluation of Cardiac Sarcoidosis.
Alvi RM; Young BD; Shahab Z; Pan H; Winkler J; Herzog E; Miller EJ
JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1284-1287. PubMed ID: 30846271
[No Abstract] [Full Text] [Related]
8. Fasting FDG PET compared to MPI SPECT in cardiac sarcoidosis.
Brancato SC; Arrighi JA
J Nucl Cardiol; 2011 Apr; 18(2):371-4. PubMed ID: 21318450
[No Abstract] [Full Text] [Related]
9. Prognostic Value of
Manabe O; Koyanagawa K; Hirata K; Oyama-Manabe N; Ohira H; Aikawa T; Furuya S; Naya M; Tsujino I; Tomiyama Y; Otaki Y; Anzai T; Tamaki N
JACC Cardiovasc Imaging; 2020 Apr; 13(4):1096-1097. PubMed ID: 31954654
[No Abstract] [Full Text] [Related]
10. 18F-FLT PET imaging in a patient with sarcoidosis with cardiac involvement.
Norikane T; Yamamoto Y; Maeda Y; Noma T; Nishiyama Y
Clin Nucl Med; 2015 May; 40(5):433-4. PubMed ID: 25546198
[TBL] [Abstract][Full Text] [Related]
11. Effect of Corticosteroid Dose and Duration on 18-Fluorodeoxyglucose Positron Emission Tomography in Cardiac Sarcoidosis.
Okada DR; Saad E; Wand AL; Griffin JM; Kasper EK; Chen EH; Chrispin J; Tandri H; Solnes LB; Gilotra NA
JACC Cardiovasc Imaging; 2020 May; 13(5):1280-1282. PubMed ID: 31954655
[No Abstract] [Full Text] [Related]
12. Metabolism-perfusion imaging to predict disease activity in cardiac sarcoidosis.
Isiguzo M; Brunken R; Tchou P; Xu M; Culver DA
Sarcoidosis Vasc Diffuse Lung Dis; 2011 Jul; 28(1):50-5. PubMed ID: 21796891
[TBL] [Abstract][Full Text] [Related]
13. (18)F-FDG PET/CT for the assessment of myocardial sarcoidosis.
Skali H; Schulman AR; Dorbala S
Curr Cardiol Rep; 2013 May; 15(5):352. PubMed ID: 23504346
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET/CT for the assessment of myocardial sarcoidosis.
Skali H; Schulman AR; Dorbala S
Curr Cardiol Rep; 2013 Apr; 15(4):352. PubMed ID: 23544184
[TBL] [Abstract][Full Text] [Related]
15. Clinical Utility of Combined FDG-PET/MR to Assess Myocardial Disease.
Abgral R; Dweck MR; Trivieri MG; Robson PM; Karakatsanis N; Mani V; Padilla M; Miller M; Lala A; Sanz J; Narula J; Fuster V; Contreras J; Kovacic JC; Fayad ZA
JACC Cardiovasc Imaging; 2017 May; 10(5):594-597. PubMed ID: 27372018
[No Abstract] [Full Text] [Related]
16. The role of F18-fluorodeoxyglucose positron emission tomography in identifying patients at high risk for lethal arrhythmias from cardiac sarcoidosis and the use of serial scanning to guide therapy.
Paz YE; Bokhari S
Int J Cardiovasc Imaging; 2014 Feb; 30(2):431-8. PubMed ID: 24293048
[TBL] [Abstract][Full Text] [Related]
17. PET/CT Evaluation of Cardiac Sarcoidosis.
Bois JP; Muser D; Chareonthaitawee P
PET Clin; 2019 Apr; 14(2):223-232. PubMed ID: 30826020
[TBL] [Abstract][Full Text] [Related]
18. Is there an association between clinical presentation and the location and extent of myocardial involvement of cardiac sarcoidosis as assessed by ¹⁸F- fluorodoexyglucose positron emission tomography?
Mc Ardle BA; Birnie DH; Klein R; de Kemp RA; Leung E; Renaud J; DaSilva J; Wells GA; Beanlands RS; Nery PB
Circ Cardiovasc Imaging; 2013 Sep; 6(5):617-26. PubMed ID: 23884290
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Value of Combined Assessments of Late Gadolinium Enhancement and Fluorodeoxyglucose Uptake in Cardiac Sarcoidosis.
Kazui S; Takenaka S; Nagai T; Tsuneta S; Hirata K; Kato Y; Komoriyama H; Kobayashi Y; Takahashi A; Kamiya K; Temma T; Sato T; Tada A; Yasui Y; Nakai M; Sato T; Tsujino I; Kudo K; Konno S; Anzai T
JACC Cardiovasc Imaging; 2024 Jun; 17(6):710-712. PubMed ID: 38520428
[No Abstract] [Full Text] [Related]
20. PET Cardiac Imaging (Perfusion, Viability, Sarcoidosis, and Infection).
Manapragada PP; Andrikopoulou E; Bajaj N; Bhambhvani P
Radiol Clin North Am; 2021 Sep; 59(5):835-852. PubMed ID: 34392922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
